EUVIMEDEUVIMED entdecken
Crossref

Prescribing of High‐Risk Medications for Older Adults with Rheumatic Disease

Christine Anastasiou, Eric Roberts, Karen H. Costenbader, Rachael Stovall, Stephen Shiboski, Daniel Ciccarone, Michael A. Steinman, Gabriela Schmajuk, Jinoos Yazdany

Arthritis & Rheumatology · 20.11.2026

DOI: 10.1002/art.70400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 20.11.2026. Verfasst von Christine Anastasiou und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Older adults with rheumatic diseases often experience multi‐morbidity and polypharmacy, potentially increasing their risk of adverse events from high‐risk medications (HRMs).

Objective

Evaluate the prevalence, characterize HRM prescriptions by prescriber characteristics, and identify patient‐level factors associated with HRM prescribing among older adults with rheumatic diseases.

Design

National cohort study using the American College of Rheumatology's Rheumatology Informatics System for Effectiveness (RISE) registry, linked to Medicare Parts A, B, and D.

Setting

Electronic health record‐based data from practices representing approximately one‐third of U.S. rheumatologists.

Participants

Medicare‐enrolled adults ≥65 years with ≥2 visits in 2021 at RISE participating practices and ≥2 ICD‐10 codes for selected rheumatic diseases.

Measurements

The primary outcome was prescription for a HRM. Logistic regression models were used to predict exposure to any HRM using generalized estimating equations to account for clustering of patients within practices.

Results

Among 45,455 older adults (mean age 75.8±6.4 years; 76.9% female), 13,977 (30.7%) received ≥1 HRM. Prescriptions predominantly originated from non‐rheumatology clinicians (82.3%). Common HRMs included skeletal muscle relaxants, first‐generation antihistamines, antidepressants with strong anticholinergic activity, non‐benzodiazepine benzodiazepine receptor agonist hypnotics (“Z‐drugs”), and antispasmodics. In adjusted analyses, patients with axial spondyloarthritis (OR 1.40, 95%CI 1.20‐1.62) and Sjögren's disease (OR 1.39, 95%CI 1.04‐1.86) had the highest odds of receiving a HRM compared with rheumatoid arthritis.

Conclusions

High‐risk medications are frequently prescribed to older adults with rheumatic diseases, exceeding the prevalence reported in the general Medicare population. These findings highlight the need for individualized medication review and enhanced cross‐specialty collaboration when managing this population.

Zitieren

APA

Anastasiou, C., Roberts, E., Costenbader, K. H., Stovall, R., Shiboski, S., Ciccarone, D., Steinman, M. A., Schmajuk, G., & Yazdany, J. (2026). Prescribing of High‐Risk Medications for Older Adults with Rheumatic Disease. Arthritis & Rheumatology. https://doi.org/10.1002/art.70400

Vancouver

Anastasiou C, Roberts E, Costenbader KH, Stovall R, Shiboski S, Ciccarone D, et al. Prescribing of High‐Risk Medications for Older Adults with Rheumatic Disease. Arthritis & Rheumatology. 2026. doi:10.1002/art.70400

BibTeX
@article{Anastasiou2026,
  author = {Anastasiou, Christine and Roberts, Eric and Costenbader, Karen H. and Stovall, Rachael and Shiboski, Stephen and Ciccarone, Daniel and Steinman, Michael A. and Schmajuk, Gabriela and Yazdany, Jinoos},
  title = {Prescribing of High‐Risk Medications for Older Adults with Rheumatic Disease},
  journal = {Arthritis & Rheumatology},
  year = {2026},
  doi = {10.1002/art.70400}
}
Kostenlos starten →